Gout
No evidence cannabis treats gout — and observational studies link cannabis smoking to higher uric acid. This is a caution, not a treatment.
Pain Unsupported
What the research says
A 2024 systematic review of cannabis in rheumatic diseases lists gout among the conditions where cannabis has been studied — but in practice there are essentially no gout-specific trials. What exists is a small number of observational studies, and they point the wrong way: cannabis smoking has been associated with significantly higher serum uric acid levels, and elevated urate is the root cause of gout attacks.
For gout-adjacent joint inflammation there is some CBD research, but it is in arthritis generally — no studies at all have looked at CBD for gout specifically. Reviews explicitly note the evidence is absent.
The honest caveats
Gout is a crystallopathy: urate crystals inflame a joint, and treatment is about lowering uric acid (allopurinol, diet) and aborting flares (NSAIDs, colchicine, steroids). Cannabis does neither. If you have gout and want to explore anti-inflammatory options, talk to your doctor — but the evidence-based path is established gout treatment, and smoking or vaping cannabis is more likely to raise your uric acid than help. A topical CBD cream on a flaring joint is unlikely to hurt, but expect nothing from it either.
Compounds to explore
These are the compounds — terpenes and cannabinoids — that the research connects to this condition. They are starting points for reading a COA or choosing a product, not prescriptions. Each has its own guide with more detail.
Cannabinoid CBD Anti-inflammatory interest from joint research, but there are zero gout-specific studies. Terpene beta-caryophyllene Anti-inflammatory terpene; theoretical only. Cannabinoid THC Cannabis smoking was associated with higher serum uric acid in observational studies — the wrong direction for gout.